Ok Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 13, 2021 at 03:34 pm EDT
Share
OK Biotech Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 295.945 million compared to TWD 370.790 million a year ago. Operating income was TWD 18.080 million compared to TWD 45.765 million a year ago. Net income was TWD 29.763 million compared to TWD 46.674 million a year ago. Basic earnings per share was TWD 0.32 compared to TWD 0.61 a year ago. Diluted earnings per share was TWD 0.3 compared to TWD 0.57 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
